Piper Jaffray is out with its report today on Vitamin Shoppe VSI, raising its price target from $34 to $36.
In a note to clients, Piper Jaffray writes, "We are raising our F11 EPS estimates and 12-month PT on VSI following another strong quarter of comp and GM rate performance. Our 12-month PT increases from $34 to $36, applying the same 25x multiple to our increased F11 EPS estimate. We continue to view VSI as a market share gainer in an industry growing in the mid-single digit range. Reiterate Overweight."
Shares of VSI closed Wednesday at $33.65.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in